YU9800A - Farmaceutska suspenzija koja sadrži nevirapin hemihidrat - Google Patents

Farmaceutska suspenzija koja sadrži nevirapin hemihidrat

Info

Publication number
YU9800A
YU9800A YU9800A YU9800A YU9800A YU 9800 A YU9800 A YU 9800A YU 9800 A YU9800 A YU 9800A YU 9800 A YU9800 A YU 9800A YU 9800 A YU9800 A YU 9800A
Authority
YU
Yugoslavia
Prior art keywords
pharmaceutical suspension
nevirapine hemihydrate
nevirapine
hemihydrate
pharmaceutical
Prior art date
Application number
YU9800A
Other languages
English (en)
Inventor
Karl Georg Grozinger
Amale Ayoub Hawi
Original Assignee
Boehringer Ingelheim Pharmaceuticals Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22006658&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU9800(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharmaceuticals Inc. filed Critical Boehringer Ingelheim Pharmaceuticals Inc.
Publication of YU9800A publication Critical patent/YU9800A/sh
Publication of RS49808B publication Critical patent/RS49808B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Vodena farmaceutska suspenzija sastoji se uglavnom od nevirapin hemihidrata čije su čestice veličine između oko 1 i 150 mikrometara u prečniku.[An aqueous pharmaceutical suspension consisting essentially of nevirapine hemihydrate having a particle size between about 1 and 150 microns in diameter.
YUP-98/00A 1997-08-25 1998-08-11 Farmaceutska suspenzija koja sadrži nevirapin hemihidrat RS49808B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5680397P 1997-08-25 1997-08-25

Publications (2)

Publication Number Publication Date
YU9800A true YU9800A (sh) 2001-12-26
RS49808B RS49808B (sr) 2008-08-07

Family

ID=22006658

Country Status (38)

Country Link
US (2) US6172059B1 (sh)
EP (1) EP1019058B1 (sh)
JP (1) JP3472261B2 (sh)
KR (1) KR100426516B1 (sh)
CN (1) CN1197578C (sh)
AR (2) AR016869A1 (sh)
AT (1) ATE326971T1 (sh)
AU (1) AU742761B2 (sh)
BG (1) BG64337B1 (sh)
BR (1) BR9811994B1 (sh)
CA (1) CA2301646C (sh)
CL (1) CL2008003111A1 (sh)
CO (1) CO4970742A1 (sh)
CY (1) CY1105228T1 (sh)
CZ (1) CZ290667B6 (sh)
DE (1) DE69834655T2 (sh)
DK (1) DK1019058T3 (sh)
EG (1) EG24075A (sh)
ES (1) ES2265666T3 (sh)
HK (1) HK1027975A1 (sh)
HR (1) HRP980461B1 (sh)
HU (1) HU226063B1 (sh)
ID (1) ID21650A (sh)
IL (1) IL134185A (sh)
MY (1) MY122272A (sh)
NO (1) NO326226B1 (sh)
NZ (1) NZ503414A (sh)
PE (1) PE105799A1 (sh)
PL (1) PL192361B1 (sh)
PT (1) PT1019058E (sh)
RS (1) RS49808B (sh)
RU (1) RU2196584C2 (sh)
SA (1) SA98190680B1 (sh)
TR (1) TR200000490T2 (sh)
TW (1) TW450812B (sh)
UA (1) UA44370C2 (sh)
WO (1) WO1999009990A1 (sh)
ZA (1) ZA987623B (sh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002092095A1 (en) * 2001-05-11 2002-11-21 Boehringer Ingelheim International Gmbh Use of nevirapine to treat or prevent lipid pathology in patients with hiv that is resistant to nevirapine
EP1504040A1 (en) * 2002-04-23 2005-02-09 Boehringer Ingelheim Pharmaceuticals Inc. Method for reduction of residual organic solvent in carbomer
AU2006286314A1 (en) * 2005-08-31 2007-03-08 Cipla Limited Pharmaceutical combinations containing lamivudine, stavudine and nevirapine
EP2306980A2 (en) * 2008-06-30 2011-04-13 Tibotec Pharmaceuticals Powders for reconstitution
US9273049B2 (en) * 2009-11-10 2016-03-01 North-West University Method for increasing the solubility of nevirapine
BR112012014762A2 (pt) * 2009-12-17 2016-03-29 Univ Northwest forma polimorfa de nevirapina e sua preparação

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5366972A (en) * 1989-04-20 1994-11-22 Boehringer Ingelheim Pharmaceuticals, Inc. 5,11-dihydro-6H-dipyrido(3,2-B:2',3'-E)(1,4)diazepines and their use in the prevention or treatment of HIV infection
CA2030056C (en) * 1989-11-17 1995-10-17 Karl D. Hargrave 5,11-dihydro-6h-dipyrido[3,2-b:2',3'-e][1,4]diazepines and their use in the prevention or treatment of hiv infection
US5571912A (en) * 1990-10-19 1996-11-05 Boehringer Ingelheim Pharmaceuticals, Inc. Method for the preparation of 5,11-dihydro-6h-dipyrido [3,2-b:2',3'-e][1,4]diazepines
DE4403311C1 (de) * 1994-02-03 1995-04-20 Boehringer Ingelheim Kg Verfahren zur Herstellung von Nevirapine (11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2',3'-e][1,4-diazepin]-6-on)

Also Published As

Publication number Publication date
CA2301646C (en) 2008-11-18
PE105799A1 (es) 1999-11-16
BR9811994A (pt) 2000-09-05
IL134185A (en) 2005-11-20
TW450812B (en) 2001-08-21
RS49808B (sr) 2008-08-07
BG64337B1 (bg) 2004-10-29
BR9811994B1 (pt) 2013-11-19
WO1999009990A1 (en) 1999-03-04
AR016869A1 (es) 2001-08-01
AU742761B2 (en) 2002-01-10
PL338828A1 (en) 2000-11-20
AU8777198A (en) 1999-03-16
ID21650A (id) 1999-07-08
DK1019058T3 (da) 2006-06-12
EP1019058A1 (en) 2000-07-19
HUP0003093A2 (hu) 2001-08-28
EG24075A (en) 2008-05-11
CA2301646A1 (en) 1999-03-04
EP1019058A4 (en) 2004-11-10
CY1105228T1 (el) 2010-03-03
KR100426516B1 (ko) 2004-04-13
IL134185A0 (en) 2001-04-30
UA44370C2 (uk) 2002-02-15
ES2265666T3 (es) 2007-02-16
BG104133A (en) 2000-08-31
DE69834655D1 (de) 2006-06-29
ZA987623B (en) 2000-03-22
CL2008003111A1 (es) 2009-09-11
EP1019058B1 (en) 2006-05-24
DE69834655T2 (de) 2006-12-14
SA98190680B1 (ar) 2006-04-04
CN1197578C (zh) 2005-04-20
TR200000490T2 (tr) 2000-08-21
PL192361B1 (pl) 2006-10-31
JP3472261B2 (ja) 2003-12-02
HU226063B1 (hu) 2008-04-28
CZ2000694A3 (cs) 2000-09-13
ATE326971T1 (de) 2006-06-15
PT1019058E (pt) 2006-08-31
HK1027975A1 (en) 2001-02-02
NO20000906L (no) 2000-02-24
US6172059B1 (en) 2001-01-09
JP2001513564A (ja) 2001-09-04
HRP980461A2 (en) 1999-06-30
AR083451A2 (es) 2013-02-27
RU2196584C2 (ru) 2003-01-20
NO326226B1 (no) 2008-10-20
KR20010023257A (ko) 2001-03-26
NZ503414A (en) 2002-11-26
US6255481B1 (en) 2001-07-03
CO4970742A1 (es) 2000-11-07
NO20000906D0 (no) 2000-02-24
MY122272A (en) 2006-04-29
CN1268055A (zh) 2000-09-27
HRP980461B1 (en) 2002-08-31
CZ290667B6 (cs) 2002-09-11

Similar Documents

Publication Publication Date Title
AU6675398A (en) Aqueous dispersion of hydrophobic particles and films produced thereby
AU8782098A (en) Loading and release of water-insoluble drugs
HUP0001546A3 (en) Coated particles, methods of making and using
AU1142097A (en) Device, system and method for implantation of filaments and particles in the body
EP0600529A3 (en) Preparation and magnetic properties of very small magnetite-dextran particles.
AU4987700A (en) Polymerized modified particles and methods of making the same
ZA985451B (en) Aqueous dispersions of fluoropolymers of different particle size
ZA961205B (en) Aqueous lecithin-based release aids and methods of using the same
AU4136196A (en) Triaxial normal and shear force sensor
AU5415596A (en) A constitutively active phosphatidylinositol 3-kinase and uses thereof
EP0435379A3 (en) Suspension, coating, agglomeration and uses of imidoperoxycarboxylic acids
PL310038A1 (en) Glycinamide derivatives, methods of obtaining them and drugs containing such derivatives
AU1925895A (en) 2-chloro and 2-bromo derivatives of 1,5-iminosugars
AU6164696A (en) High affinity tamoxifen derivatives and uses thereof
AU8379398A (en) Nanocrystal dispersed amorphous alloys and method of preparation thereof
EP0799791A4 (en) HYDROPHOBIC METAL OXIDE POWDER AND USE THEREOF
MY122272A (en) Pharmaceutical suspension comprising nevirapine hemihydrate
AU4553297A (en) Spherical magnetic particles
DE59505413D1 (de) Präparationen von monodispersen kugelförmigen Oxidpartikeln
AU3681795A (en) Polypeptide agonists and antagonists of human interleukin-8
EP0747351A3 (en) Thiocationic lipids, pharmaceutical compositions and their methods of use
AU4165999A (en) Pesticide preparations in the form of aqueous suspension
EP0810308A3 (en) An ultrafine a1 particle and production method thereof
AU4524696A (en) Preparation and use of magnetically susceptible polymer particles
IL116164A0 (en) Proteins having fibrinolytic and thrombin-inhibiting properties